ARCHIVES

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 21 | May 24, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: RFPs For Recompeting Frederick Contract Still Being Drafted; Panel Meets April 13

April 10, 1981

Patient’s Husband To Fund Fellowship At Dana-Farber

September 8, 1995

Regulatory Agencies: Health Warnings Sought on Cigars

July 23, 1999

Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials

March 26, 2004

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

Soybean Studies, Computing Support Recompetition Ok’d

November 9, 1990